Investor Presentaiton slide image

Investor Presentaiton

8 + IDEAYA Precision Medicine Oncology Drug Discovery Platform Structure-Based Drug Design & Proprietary Chemical Library Enable "Hard to Drug" Targets Structural Biology & Structure Based Drug Design Full suite of capabilities in structural biology, biophysics, & computational chemistry Ligand bound co-crystal structures resolved to enable Structure Based Drug Design for each of the Synthetic Lethality drug-discovery programs Multiple potential "first-in-world" co-crystal structures resolved, including for PARG, Pol Theta Helicase and Werner Helicase INQUIRE™ Proprietary Chemical Library Expert-curated HTS library to enhance hit discovery capabilities against novel SL targets classes, such as helicases and endonucleases Enhances IDEAYA's SL Drug Discovery Platform and competitive differentiation HARMONY™ Proprietary Machine-Learning Internal Machine-Learning engine empowers discovery platform through effective prioritization leading to efficient SAR cycles IDEAVA BIOSCIENCES
View entire presentation